Live feed
Filing
SC 13G
SC 13G0001415889-19-000287·Pherin Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
VISTAGEN THERAPEUTICS INC
Security class unavailable · CUSIP: 92840H202
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-19-000287
- Form type
- SC 13G
- Filer
- Pherin Pharmaceuticals, Inc.
- CIK
- CIK 1074733
- Filed
- Mar 08, 2019
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership